By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.

Sunday, June 1, 2008

Erbitux adds 5 weeks to lung cancer survival - study (Reuters via Yahoo! India News)

CHICAGO (Reuters) - Lung cancer patients treated in a large clinical trial with ImClone Systems Inc's Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to results from the study released on Sunday.

No comments: